At the time of writing, Dexcom Inc [DXCM] stock is trading at $75.32, up 2.06%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The DXCM shares have gain 5.56% over the last week, with a monthly amount drifted -15.16%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on February 03, 2025, when Redburn Atlantic upgraded its rating to a Buy and also boosted its price target to $115 from $85. Previously, Robert W. Baird upgraded its rating to Outperform on January 16, 2025, and elevated its price target to $104. On July 26, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $80 on the stock. JP Morgan downgraded its rating to a Neutral and decreased its price target to $75 on July 26, 2024. Redburn Atlantic initiated its recommendation with a Neutral and recommended $130 as its price target on May 30, 2024. RBC Capital Mkts started tracking with a Outperform rating for this stock on March 12, 2024, and assigned it a price target of $165.
For the past year, the stock price of Dexcom Inc fluctuated between $62.34 and $142.00. Currently, Wall Street analysts expect the stock to reach $120 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $75.32 at the most recent close of the market. An investor can expect a potential return of 59.32% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
According to Dexcom Inc [NASDAQ:DXCM], the company’s sales were 4.03B for trailing twelve months, which represents an 7.64% jump. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.18%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.09, Equity is 0.26 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 74.68 points at the first support level, and at 74.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 75.89, and for the 2nd resistance point, it is at 76.45.
Ratios To Look Out For
It is important to note that Dexcom Inc [NASDAQ:DXCM] has a current ratio of 1.47. As well, the Quick Ratio is 1.28, while the Cash Ratio is 0.21. Considering the valuation of this stock, the price to sales ratio is 7.30, the price to book ratio is 14.00 and price to earnings (TTM) ratio is 52.87.
Transactions by insiders
Recent insider trading involved Heller Bridgette P, Director, that happened on Mar 17 ’25 when 352.0 shares were sold. Director, Heller Bridgette P completed a deal on Mar 17 ’25 to buy 352.0 shares. Meanwhile, EVP, Chief Operating Officer Leach Jacob Steven sold 14076.0 shares on Mar 12 ’25.
